Thyme Care

Thyme Care is a value-based oncology management platform with the mission to improve the quality of life for people diagnosed with cancer. The company provides personalized, clinically coordinated care through a combination of human guidance, software, and analytics, ensuring timely access to the right care and ongoing support through evidence-based interventions. Founded by oncology industry veterans and clinicians, Thyme Care prioritizes deep provider relationships and integrates with health plans' existing infrastructure to deliver value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed by venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, the company partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. Thyme Care's last investment was a $55.00M Series C investment on 16 July 2024, with participation from Town Hall Ventures, AlleyCorp, Andreessen Horowitz/a16z, CVS Health, Concord Health Partners, Echo Health Ventures, Foresite Capital, and Frist Cressey Ventures. The company, founded in 2020, is based in the United States. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.